Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer
Clinical trial NCT06145750 · COMPLETED
Trial details
- NCT number
- NCT06145750
- Sponsor
- Delfi Diagnostics Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2025-08-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.